glp 1 ketoacidosis When the Transition Goes Wrong: A Rare Case of Diabetic Ketoalkalosis After Transitioning to Tirzepatide in Insulin-dependent Type 2 Diabetes GLP-1 receptor agonists causing euglycemic

It can be used in clinician-led plans where sleep is one part of a bigger goal set

Kappes, U

However, through several magnetic resonance spectroscopy studies (MRS) it has been shown that GSH levels are significantly decreased in the hippocampus, frontal, and cingulate cortices early in AD progression (Vilhardt et al., 2017)

[1] The most frequently reported side effects of GLP-1 medications are gastrointestinal in nature, reflecting the drugs' effects on the digestive system

If further blood sugar control is needed, the dose can be adjusted in 2.5 mg increments every 4 weeks, up to a maximum of 15 mg weekly

Neurol.India 2008;56(3):391-393